TITLE

Protherics launches IIa trial of vaccine for hypertension

PUB. DATE
July 2008
SOURCE
Cardiovascular Devices & Drugs;Jul2008, Vol. 14 Issue 7, p18
SOURCE TYPE
Periodical
DOC. TYPE
Article
ABSTRACT
The article reports on the enrollment of first patient in a Phase IIa study of Angiotensin Therapeutic Vaccine (ATV) from Protherics for the treatment of hypertension in Great Britain. The company claims that a vaccine approach which may involve three injections and a booster, should enhance patient compliance with treatment. The clinical trial will evaluate the safety and tolerability of the vaccine which includes the CoVaccine HT vaccine adjuvant from Protherics.
ACCESSION #
33516927

 

Related Articles

  • Hypertension's shot in the arm. Adams, Jill U. // Nature Biotechnology;Dec2008, Vol. 26 Issue 12, p1327 

    This article discusses research by the biotechnology companies Cytos Biotechnology AG and Protherics PLC into vaccines that treat hypertension as an immunologic disorder. The Protherics medication uses an angiotensin I hormone peptide analog in combination with the adjuvant keyhole limpet...

  • A Dose-Escalation Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Efficacy of 2 and 4 Weeks of Twice-Daily Ocular Trabodenoson in Adults with Ocular Hypertension or Primary Open-Angle Glaucoma. Myers, Jonathan S.; Sall, Kenneth N.; DuBiner, Harvey; Slomowitz, Natanya; McVicar, William; Rich, Cadmus C.; Baumgartner, Rudolf A. // Journal of Ocular Pharmacology & Therapeutics;Oct2016, Vol. 32 Issue 8, p555 

    Purpose: To evaluate the safety and ocular hypotensive efficacy of 4 trabodenoson doses administered twice daily over 14 or 28 days in subjects with ocular hypertension or primary open-angle glaucoma (POAG).Methods: In this multicenter, randomized, double-masked,...

  • Immunogenicity and safety of quadrivalent human papillomavirus types 6/11/16/18 recombinant vaccine in chronic kidney disease stage IV, V and VD. Praditpornsilpa, Kearkiat; Kingwatanakul, Pornchai; Deekajorndej, Tawatchai; Rianthavorn, Pornpimol; Susantitaphong, Paweena; Katavetin, Pisut; Tiranathanakul, Khajohn; Srisawat, Nattachai; Tungsanga, Kriang; Eiam-Ong, Somchai; Townamchai, Natavudh // Nephrology Dialysis Transplantation;Jan2017, Vol. 32 Issue 1, p132 

    Background. Up to >80% of sexually active adults will become infected with human papillomavirus (HPV) during their lifetime. Persistent HPV infection can result in cervical, vulvovaginal, penile and anogenital cancer. Clinical studies have shown the efficacy of three doses of quadrivalent...

  • DNDi launches Phase I in-human clinical trial for promising oral drug for sleeping sickness.  // Biomedical Market Newsletter;3/21/2012, Vol. 21, p1 

    The article offers information on the commencement of phase first clinical trial by the Drugs for Neglected Diseases initiative in order to check the safety and tolerability of its oral drug, Oxaborole SCYX-7158 used for treatment against human African trypanosomiasis.

  • Glaucoma treatment adherence difficult to measure, improve. Cimberle, Michela // Ocular Surgery News;8/25/2012, Vol. 30 Issue 16, p22 

    No abstract available.

  • Adherence to medications: Towards a shared understanding. Mitchell, Gary // Nurse Prescribing;Nov2014, Vol. 12 Issue 11, p564 

    Patient adherence to medication is a complex issue that is important to patients, health professionals, policy makers and health researchers. This article will provide some background to the phenomenon in relation to adherence, its cost to the health service, how adherence is measured in health...

  • Getting young patients to take their medicine. ZIMBECK, PAUL // Clinical Advisor;Feb2012, Vol. 15 Issue 2, p49 

    The article focuses on the problems arising in medication adherence among children with chronic health problems. It says that the factors affecting the medication adherence in children include stress,family conflict, and hassles of daily living. Furthermore, it mentions that medication adherence...

  • To improve compliance in glaucoma patients, EyeMDs can keep it simple. Groves, Nancy // Ophthalmology Times;Oct2015, Vol. 40 Issue 17, p38 

    The article discusses ways that can help ophthalmologists ensure that their patients comply with their glaucoma medications. Topics covered include common reasons for non-compliance with glaucoma medications, the need to prescribe cheaper and more effective medicines to the patients, addition of...

  • Medication (Re)fill Adherence Measures Derived from Pharmacy Claims Data in Older Americans: A Review of the Literature. Sattler, Elisabeth; Lee, Jung; Perri, Matthew // Drugs & Aging;2013, Vol. 30 Issue 6, p383 

    Medication nonadherence is a significant public health problem that affects the health and well-being of older Americans while burdening the US healthcare system. Pharmacy claims data have gained importance in deriving objective medication (re)fill adherence measures; however, little is known...

Share

Read the Article

Courtesy of VIRGINIA BEACH PUBLIC LIBRARY AND SYSTEM

Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics